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Abstract
Background and Objective: The Wnt/β-catenin signaling pathway is essential for controlling bone mass; however,
little is known about the variable effects of the constitutive activation of β-catenin (CA-β-catenin) on bone growth and
remodeling at different postnatal stages. The goal of the present study was to observe the effects of CA-β-catenin on
vertebral bone growth and remodeling in mice at different postnatal stages. In particular, special attention was paid to
whether CA-β-catenin has detrimental effects on these processes.
Methods: Catnblox(ex 3) mice were crossed with mice expressing the TM-inducible Cre fusion protein, which could
be activated at designated time points via injection of tamoxifen. β-catenin was stabilized by tamoxifen injection 3
days, and 2, 4, 5, and 7 months after birth, and the effects lasted for one month. Radiographic imaging, micro-
computed tomography, immunohistochemistry, and safranin O and tartrate-resistant acid phosphatase staining were
employed to observe the effects of CA-β-catenin on vertebral bone growth and remodeling.
Results: CA-β-catenin in both early (3 days after birth) and late stages (2, 4, 5, and 7 months after birth) increased
bone formation and decreased bone resorption, which together increased vertebral bone volume. However, when β-
catenin was stabilized in the early stage, vertebral linear growth was retarded, and the mice demonstrated shorter
statures. In addition, the newly formed bone was mainly immature and located close to the growth plate. In contrast,
when β-catenin was stabilized in the late stage, vertebral linear growth was unaffected, and the newly formed bone
was mainly mature and evenly distributed throughout the vertebral body.
Conclusions: CA-β-catenin in both early and late stages of growth can increase vertebral bone volume, but β-
catenin has differential effects on vertebral growth and remodeling when activated at different postnatal stages.
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Introduction
The evolutionarily conserved Wnt signaling pathway mainly
includes the canonical Wnt/β-catenin and non-canonical
pathways that can be further subdivided into planar cell polarity
and Wnt/Ca2+ pathways. Both canonical and non-canonical
signaling pathways participate in many physiological and
pathological processes [1-4]. Several lines of evidence suggest
that Wnt/β-catenin signaling is essential for bone formation and
resorption [4-8]. Activating mutations in lipoprotein receptor-
related protein 5 (LRP5), a Wnt co-receptor, induce high bone
mass phenotype, whereas inactivating mutations cause
osteoporosis-pseudoglioma syndrome, characterized by
osteoporosis and blindness [9,10]. Studies in animal models
with genetically modified LRP5 protein support these findings
[11]. Overexpression of the Wnt ligand inhibitor Dickkopf-1,
induced low bone mass and decreased bone formation [12]. In
contrast, sclerostin (Wnt ligand inhibitor) knockout mice
exhibited increased bone formation and high bone mass [13].
These results suggest that the canonical Wnt signaling
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pathway plays an important role in controlling bone formation
and resorption, thus presenting a potential target for the
development of novel bone-building drugs.
Wnt/β-catenin signaling involves multiple steps that may be
considered for pharmacological intervention [5,14]. Enhanced
Wnt/β-catenin signaling or deficiency/neutralization of Wnt
antagonists is associated with increased bone formation and/or
decreased bone resorption, suggesting potential therapeutic
application in low bone volume conditions [15-22]. However,
controversies exist with regard to several issues, including
safety, dosage, duration of treatment, and mechanisms of
intervention on osteoblastogenesis and osteoclastogenesis
[22-26]. To date, there have been no data demonstrating the
effects of Wnt/β-catenin signaling pathway on bone growth and
remodeling at different postnatal stages. In particular, no data
are available on whether manipulation of this signaling pathway
might have detrimental effects on bone growth.
The large number of Wnt proteins, receptors, coreceptors,
and soluble inhibitors of Wnt signaling makes it difficult to
define the specific functions of Wnt /β-catenin signaling.
Fortunately, a molecular node of canonical Wnt signaling
involves β-catenin with only one encoding gene, which offers
the possibility of genetic manipulation. Constitutive activation of
β-catenin (CA-β-catenin) can thus be induced in mice
expressing a β-catenin mutant allele in which all the serine and
threonine residues of exon 3 are phosphorylated by GSK-3β
[23]. In the present study, we investigated the effects of CA-β-
catenin on vertebral bone growth and remodeling in mice at
different stages using pro-collagen I Cre-ERTM as the promoter,
which could be activated at designated time-points via injection
of tamoxifen (TM) [27,28].
Materials and Methods
The experimental protocol was reviewed and approved by
the Ethical Committee of the Daping Hospital, Third Military
Medical University (China).
Generation of Mice and the Tamoxifen Injection
Procedure
Mice expressing the TM-inducible Cre fusion protein, Cre-
ERTM, under the control of a 3.2 kb mouse pro-collagen 1
promoter (3.2 kb Col1-Cre ERTM) active in osteoblasts,
odontoblasts and tendon fibroblasts [27,28] were generated by
TM injection and crossed with Catnb+/lox(exon 3) mice [23].
Genotyping was performed with a routine method. Briefly, DNA
was extracted from the toe of each mouse using a standard
protocol, and subjected to PCR for genotyping. The PCR
primers for Cre were 5'-CCCGCAGAACCTGAAGATG-3'
(sense) and 5'-GACCCGGCAAAACAGGTAG-3' (anti-sense),
and the PCR primers for Catnb+/lox(exon 3) mice were 5'-
AGGGTACCTGAAGCTCAGCG-3' (sense) and 5'-
CAGTGGCTGACAGCAGCTTT-3' (anti-sense).
TM (Sigma-Aldrich, St. Louis, MO, USA) was dissolved in a
small volume of ethanol and diluted with corn oil at a
concentration of 10 mg/ml [27,28]. CA-β-catenin and wild-type
mice (n=6 at each time point) were intraperitoneally injected
with TM (75 mg/kg) twice a week for one month. The start
times for TM injection were day 3, and months 2, 4, 5, and 7.
Site-specificity of Col1-Cre ERTM was examined by crossing
Col1-Cre ERTM mice with ROSA26 reporter mice. Wild-type
mice were also crossed with ROSA26 mice to serve as
controls. TM was injected as aforementioned. The specificity of
Col1-CreERTM expression was confirmed by β-gal staining.
Radiographic imaging and tissue preparation
At the designated time-points (1, 3, 5, 6 and 8 months after
birth), mice were deeply anesthetized and radiographic images
of entire skeletons obtained using a small animal X-ray
machine (Model 8050-020, Field Emission Corporation, Inc.,
McMinnville, OR, USA) [29]. After whole-body X-ray was taken,
5 ml of whole blood was removed from the mice by heart
puncture. The blood was incubated at room temperature for 30
min, and centrifuged for 5 min at 5000 rpm. The serum was
then collected and enzyme-linked immunoassay (ELISA) or
radioimmunoassay (RIA) was performed to determine the
concentration of intact N-terminal propeptide of type I
procollagen (P1NP), tartrate resistant acid phosphatase 5b
(TRAP5b), osteocalcin, C-terminal telopeptides of type I
collagen (CTX-I), according to the manufacturer’s instructions
(Immunodiagnostic Systems Ltd, Boldon, UK).
After whole-body x-ray was performed and whole blood was
taken, the mice were sacrificed by overdose of anesthesia and
the spines were removed and fixed in 4% paraformaldehyde at
4°C overnight. The fifth lumbar vertebra was cut and saved for
micro-computed tomography (microCT) examination and real-
time PCR. The samples that were left were decalcified in 10%
ethylenediaminetetraacetic acid at 4°C for 7 days. X-ray
imaging was used to determine if the samples were adequately
decalcified. Then, the third and fourth lumbar vertebrae were
tissue-processed, embedded in paraffin, and sectioned at a
thickness of 5 µm horizontally or coronally. The sections were
de-paraffined and rehydrated, and were used for hematoxylin
and eosin (H&E) staining, immunohistochemistry, TRAP
staining, and safranin O staining.
Real-time PCR
Total RNA was extracted from 100 mg of the vertebral
trabecular bone using TripureTM (Promega Corp, Madison, WI)
according to the manufacturer’s instructions. The amount of
RNA was quantified by spectrophotometry, after which cDNA
was prepared from 1.0 µg RNA. The RNA was digested with
DNase to eliminate any contaminating genomic DNA before
quantitative real-time RT-PCR was performed. Then SYBR
green detection method was used to examine the expression of
receptor activator of nuclear factor kappa B ligand (RANKL),
osteoprotegerin (OPG), TRCAP, tissue non-specific alkaline
phosphatase (TNAP), RunX2, and bone sialoprotein (BSP).
Glyceraldehyde-3-phosphatedehydrogenase (GAPDH) served
as a control and the expression of a given gene was expressed
as proportion relative to the average value of GAPDH. The
relative ratio of RANKL:OPG expression was calculated and
used for statistics. The primers used were sythesized by
Sangon Biotech (Shang Hai, China) and are shown in Table 1.
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MicroCT examination
The fifth lumbar vertebrae and tibia of mice from each group
were dissected and scanned in a micro-CT imaging system
(Scanco Medical, Bassersdorf, Switzerland), as described
previously [29]. The scanning medium was ethanol, the x-ray
tube potential was 45 kVp, and the voxel size was 10 µm3.
Images were reconstructed and analyzed with EVS Beam
software using a global threshold of 1400 Hounsfield units.
Total vertebral bone volume fraction was calculated as the
percentage of bone volume to total volume (BV/TV) of fifth
lumbar vertebra. The mean trabecular thickness (Tb.Th),
trabecular separation (Tb. Sp), and trabecular number (Tb.N)
were also calculated [30]. As for the tibia, quantitative
morphometry data were based on region of interest as
following: trabecular bone region starting from growth plate
reference level extending 44 slices (0.8 mm) distally, while
cortical bone starting from mid-diaphysis extending 22 slices
(0.4 mm) proximally. BV/TV, Tb.Th, Tb. Sp and Tb.N were
qualified in trabecular bone region of tibia, while average
cortical thickness (Ct.Th), total cross-sectional area (Tt.Ar),
cortical bone area (Ct.Ar), cortical area fraction (Ct.Ar/Tt.Ar)
were qualified in cortical bone region of tibia.
Immunohistochemical analysis
Immunohistochemistry was performed according to a
previous report [31]. Briefly, 5-µm sections were blocked with
10% H2O2 at room temperature for 10 min, followed by
treatment with 3% bovine serum albumin (BSA) at room
temperature for 1 h. Sections were incubated with primary
antibodies diluted at the appropriate concentrations in 2%
BSA/0.1 M phosphate buffered saline (PBS) overnight at 4°C,
washed in PBS, and further incubated with a biotinylated IgG
antibody at room temperature for 1 h. Next, slides were treated
with ABC reagents (Boster, Wuhan, China), and signals for
antibody binding visualized with diaminobenzidine (Boster)
substrate. Counterstaining was performed with Methyl Green.
Slides were fully rinsed with 0.1 M PBS or distilled water
between individual steps.
The primary antibodies used included goat TNAP (1:200),
goat polyclonal Runx2 (1:300) and rabbit anti- BSP (1:300). All
primary antibodies were purchased from Santa Cruz
Biotechnology, Inc (CA, USA), and biotinylated goat anti-
mouse, rabbit anti-goat, and goat anti-rabbit IgG acquired from
Boster. To obtain the percentage of cells expressing a given
marker protein, pictures of each section were taken by an
Olympus microscope and digital camera under a 200x
magnification. The number of specific antigen-positive cells
was counted in five random fields. The average percentage of
positive cells and standard deviation were calculated in each
group and used for statistics.
Safranin O Staining Protocol
Rehydrated sections were stained with Weigert’s iron
hematoxylin for 1 min and rinsed in distilled water until clear.
Sections were stained sequentially with 0.02% Fast Green for 5
min, 1% acetic acid for 30 s, and 0.1% Safranin O for 20 min.
Slides were not rinsed between steps. Subsequently, slides
were rinsed in 95% alcohol for 2 min, 100% alcohol for 3 min
(twice), xylene for 2 min (twice), and coverslipped with
Permount. All chemicals were purchased from Chuandong
Corporation (Chongqing, China).
TRAP staining
Two coplin jars (A and B) were pre-heated to 37°C with 50
ml stock basic incubation medium (sodium acetate anhydrous,
9.2 g; sodium tartrate dibasic dehydrate, 11.4 g; and glacial
acetic acid, 2.8 ml dissolved in 1000 ml of distilled water and
the pH was adjusted to 4.7-5.0 with 5M sodium Hydroxide).
Then, 50 µl of 2% naphthol AS-BI phosphate substrate in
ethylene glycol monoethyl ether was added to jar A, into which
the slides were added, and incubated at 37°C for 45 min. A few
minutes before the 45 min elapsed, 1 ml of 5% pararosaniline
chloride and 1 ml of 4% sodium nitrite was mixed for 30 sec,
incubated at room temperature for 2 min without mixing, and
then transferred into jar B and mixed well. The slides from jar A
were then moved into jar B without rinsing. Incubation at room
temperature was done for 1-3 min until the color developed,
followed by rinsing and counterstaining with methyl green for 5
min, dehydration, and covering with Permount. All chemicals
were purchased from the Chuandong Corporation (Chongqing,
China).
Pictures of each section were taken under a magnification of
200×, and the number of TRAP-positive cells was counted in
five random fields. The average number and standard deviation
of TRAP-positive cells were calculated and used for statistical
analyses
Table 1. Primers used for real-time PCR.
Genes Primers
BSP F: 5’-CAATCCGTGCCACTCACT-3’, R: 5’-CAAACTCCAAGCCAAAGC-3’
GAPDH F: 5’-TCACTGCCACCCAGAAGA -3’, R: 5’-AAGTCGCAGGAGACAACC -3’
OPG F: 5’- GCATTATGACCCAGAAACT -3’, R: 5’- ACCTGAGAAGAACCCATC-3’
RANKL F: 5’- AACCAAGATGGCTTCTATTACC-3’, R: 5’- AAGGGTTGGACACCTGAATG-3’
RunX2 F: 5’-AGTCCCAACTTCCTGTGCT-3’, R: 5’-GGTGAAACTCTTGCCTCGTC-3’
TNAP F: 5’- ACGAGATGCCACCAGAGG-3’, R: 5’- AGTTCAGTGCGGTTCCAG -3’
TRAP F: 5’- GCCCTTACTACCGTTTGC-3’, R: 5’-TCTCGTCCTGAAGATACTGC-3’
doi: 10.1371/journal.pone.0074093.t001
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Statistical analysis
All data were expressed as means ± standard error.
Statistical significance was evaluated using ANOVA with
SPSS11.0 software. Data were considered significant at
P<0.05.
Results
Effect of CA-β-catenin on vertebral bone growth at
different stages after birth
The site specificity of Col1-CreERTM expression was
confirmed by β-gal staining using ROSA26 mice. Positive
staining was mainly found in osteoblasts, but not in the
chondrocytes of the growth plate (Figure S1).
During the period that we performed our experiments, wild-
type mice, Col-Cre mice, and β-catenin exon 3 fx +/+ mice
(without Col I Cre) were injected with tamoxifen. The
phenotypes of Col-Cre and β-catenin exon 3 fx +/+ mice
(without Col I Cre) were the same as wild-type mice (data not
shown). We feared that this data would make the manuscript
too complicated, so only data from wild-type mice were
presented as control in the current study. When β-catenin was
stabilized with Col1-CreERTM as a promoter from day 3 of life,
mice displayed shorter stature in their first month of life,
compared with wild-type mice. In the group with β-catenin
stabilization from month 2 to 3, mouse height was still slightly
shorter than that of wild-type, but not to a significant extent.
Interestingly, when β-catenin was stabilized from months 4, 5
and 7 of life, statures were similar to that in wild-type mice
(Figure 1).
Growth plate is the structure responsible for linear growth in
vertebrates. H&E and Safranin O staining showed that growth
plates in mice with β-catenin stabilization from day 3 were
longer than that in wild-type mice (Figures 2 and 3). The
hypertrophic layer of the growth plate was the most enlarged
part. In contrast, β-catenin stabilization at months 4, 5, and 7 of
life had no evident effect on growth plate length (Figures 2 and
3). These results clearly indicate that stabilization of β-catenin
at early stages after birth hinders vertebral linear growth in
mice.
Similar findings were observed in the long bone. When β-
catenin was stabilized from day 3 of life, the lengths of the tibia
and femur were shorter than those in wild-type mice, and the
hypertrophic layer of the growth plate was enlarged (Figure 1,
Figure S2). In contrast, when β-catenin was stabilized 4, 5, and
7 months after birth, the lengths of the long bone and growth
plate were not affected (Figure 1, Figure S2).
Effects of CA-β-Catenin on Vertebral Bone Volume at
Different Stages after Birth
The Wnt/β-catenin signaling pathway plays an important role
in controlling bone volume. Our experiments disclosed
significantly increased trabecular bone volumes in mice with
constitutive activation of β-catenin at both early (day 3) and late
stages (months 2, 4, 5 and 7), compared to wild-type mice (P
<0.05, Figure 4, Figure S3). In addition, Tb.N and Tb.Th
significantly increased in the vertebrae of CA-β-catenin mice,
and Tb. Sp significantly decreased in the vertebrae of CA-β-
catenin mice (p<0.05, Figure 4). Except for the Tb.Th, Tb.N
and Tb. Sp showed similar change in tibia of CA-β-catenin
mice (Figure S3).
However, the location and extent of maturation of excessive
formed bone varied with different stages of β-catenin
stabilization. Upon induction of β-catenin stabilization from day
3 to month 1 of life, excessive formed bone was located in
close proximity to the growth plate, while mice with β-catenin
stabilization at the late stages (2, 4, 5 and 7 months after birth)
displayed even distribution of excessive bone in the vertebral
body (Figure 2).
Safranin O is commonly employed for proteoglycan staining.
During rapid bone formation, immature bone stains positive for
Safranin O [32,33]. Our data showed that the majority of
cancellous bone in vertebral bodies of CA-β-catenin mice at
month 1 was positive for Safranin O, indicating that excessive
formed bone in vertebrae is immature. In contrast, at later
stages (2, 4, 5 and 7 months after birth), excessive formed
bone was negative for Safranin O staining (Figure 3).
Similar findings were observed in the long bone (Figure S3).
Specifically, CA-β-catenin in both the early (3 days after birth)
and late stages (2, 4, 5, and 7 months after birth) increased
trabecular bone volume in the long bone (Figure S3). However,
when β-catenin was stabilized from day 3 of life, most
cancellous bone in the long bone were Safranin-O positive. In
contrast, at later stages (2, 4, 5 and 7 months), most of the
excessive formed bone were negative for Safranin O staining
(Figure S4). CA-β-catenin had no obvious effect on cortical
bone (Figure S5).
Increased bone formation and decreased bone
resorption contribute to excessive bone volume in CA-
β-catenin mice
The balance of bone formation and bone resorption controls
bone volume. TRAP staining showed that the number of
osteoclasts in CA-β-catenin mice was lower than that in wild-
type mice in both early and late postnatal stages (p<0.05,
Figure 5A-I, Figure S6). RANKL was an important factor during
the maturation of osteoclasts, and OPG was its decoy receptor.
Real-time PCR showed that the RANKL:OPG ratio significantly
decreased in CA-β-catenin mice at each time point compared
with control mice (Figure 5J), which contributed to the
decreased number of osteoclasts in CA-β-catenin mice. TNAP
served as a useful marker of bone formation. IHC analyses
showed higher expression of TNAP protein in ca-β-catenin than
wild-type mice, indicative of increased bone formation ability
(p<0.05, Figure 6A-E). Runx2 and BSP are markers for
osteoblasts at the early and late stages, respectively [29,33].
Notably, the numbers of both Runx2 and BSP-positive cells in
CA-β-catenin mice were greater than those in wild-type mice in
both early and late postnatal stages (p<0.05, Figure 6F-J and
Figure 6K-O).
The results of real-time PCR and ELISA further supported
the histology findings. As shown in Figure 7A-C, the mRNA
expression levels of Runx2, BSP, and TNAP significantly
increased in CA-β-catenin mice compared with that in wild-type
mice. PINP and osteocalcin are markers of bone formation,
while CTX-I and TRAcP5b are markers of bone resorption. It
Effects of CA-β-Catenin on Vertebral Growth
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was found that PINP and osteocalcin serum concentrations
significantly increased in CA-β-catenin mice, whereas CTX-I
and TRAcP5b concentrations significantly decreased (p<0.05,
Figure 7).
Taken together, these results indicate that stabilization of β-
catenin in both early and late postnatal stages increases
vertebral bone formation and decreases bone resorption.
Discussion
Accumulating evidence supports the significance of Wnt/β-
catenin signaling in bone formation and bone resorption.
However, no data are available about the effect of the Wnt/β-
catenin signaling pathway on bone growth and remodeling at
different stages after birth. In the current study, we showed that
constitutive β-catenin activation at both the early and late
stages of growth results in increased bone formation and
decreased bone resorption, which concertedly increase
vertebral bone volume. However, the stabilization of β-catenin
Figure 1.  Representative x-ray images of the spine.  a-e X-ray images of the spine in wild-type and CA-β-catenin mice 1 month
(a), 3 months (b), 5 months (c), 6 months (d) and 8 months (e) after birth.
doi: 10.1371/journal.pone.0074093.g001
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at early and late stages had differential effects on vertebral
growth.
The current study found that CA-β-catenin in both the early
and late stages of growth increases bone volume by increasing
bone formation and decreasing bone resorption. However,
controversies exist regarding the role of the Wnt/β-catenin
signaling pathway in osteoblastogenesis and
osteoclastogenesis [22-26]. Using a mouse model with a
Lrp6rs/rs mutation, Kubota et al. showed that mutant mice have
low bone mass, owing to accelerated bone resorption [11].
Similar results were observed with CA-β-catenin mice [23].
However, oral administration of AZD2858, a GSK-3 inhibitor,
had no influence on the number of osteoclasts in mice [22].
Glass and colleagues suggested this difference might be
caused by the fact that Wnt/β-catenin signaling in osteoblasts
at different stages has variable effects on osteoclastogenesis
[23]. Specifically, the Wnt/β-catenin pathway in mature
osteoblasts negatively regulates osteoclastogenesis, but exerts
Figure 2.  H&E staining of coronal sections of the fourth lumbar vertebra in wild-type and CA-β-catenin mice.  Boxes in a, c,
e, g, i, k, m, o, q and s are magnified in b, d, f, h, j, l, n, p, r and t, respectively. Bars: 200 µm (a, c, e, g, I, k, m, o, q and s) and 100
µm (b, d, f, h, j, l, n, p, r and t).
doi: 10.1371/journal.pone.0074093.g002
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different effects in early osteoblasts and mesenchyaml stem
cells. In the current study, a 3.2 kb Col I Cre that mainly
activates Wnt/β-catenin in mature osteoblasts was employed
[27,28], resulting in suppression of osteoclastogenesis.
Although controversy exists, the effects of Wnt/β-catenin on
bone formation are generally considered positive [19,25,34,35].
Wnt6, Wnt10a and Wnt10b inhibit adipogenesis and stimulate
osteoblastogenesis through a β-catenin-dependent mechanism
[19]. Moreover, oral administration of different types of GSK-3
inhibitors leads to increased bone formation [20,22]. Recently it
was shown by Chen and colleagues that deletion of β-catenin
in osteoblasts greatly reduced bone formation activity and
indirectly increased osteoclast number and activity [36].
Consistent with that finding, the current study found that CA-β-
catenin in both the early and late stages increased bone
formation, which worked together with decreased bone
resorption to increase bone volume.
Another finding of the present study is that stabilization of β-
catenin at early and late stages has differential effects on
vertebral growth. When β-catenin was activated at the early
stages (from day 3 after birth up to 1 month), maturation of
vertebral growth plate was retarded in addition to increased
bone formation, and mice displayed shortened statures. In
contrast, when β-catenin was activated at the late stages (2, 4,
5 and 7 months after birth), growth plates were not significantly
affected. Our results indicate that constitutive activation of β-
catenin at the early stages has a detrimental effect on vertebral
growth. Furthermore, excessive formation of bone in early
activation mainly occurs close to the growth plate and involves
immature bone (staining positive for Safranin O), while
excessive bone formed in the late stages is evenly distributed
in the vertebral body and mature (staining negative for Safranin
O). Until now, the precise mechanisms underlying the
differential effects on vertebral growth by CA-β-catenin at
different postnatal stages have remained unknown. Since the
promoter used in the current study, pro-collagen I Cre-ERTM, is
mainly expressed in osteoblasts, but not in chondrocytes, the
effect of CA-β-catenin on the growth plate must be indirect. Our
preliminary study showed that CA-β-catenin mice
demonstrated hypophosphatemia, and a high phosphate diet
could partially rescue the phenotype of enlarged growth plate in
mice when β-catenin was stabilized at early stage (data not
shown). These data indicated that hypophosphatemia might be
the reason for retarded linear growth in CA-β-catenin mice.
Future studies are needed to investigate the reason for these
differential effects. However, regardless of the underlying
mechanisms, these discrepancies should be addressed before
therapeutics are used that target the Wnt/β-catenin signaling
pathway.
In conclusion, the present study shows that CA-β-catenin at
different stages after birth can increase vertebral bone volume.
This increased bone volume was the result of increased bone
formation and decreased bone resorption caused by CA-β-
catenin. However, CA-β-catenin induced at different stages has
differential effects on vertebral linear growth, as well as
distribution and maturation of the newly formed bone.
Figure 3.  Safranin O staining of lumbar vertebra.  a-i Safranin O staining of coronal sections of the fourth lumbar vertebra in
wild-type and CA-β-catenin mice at 1 month (a, b, e and f), 3 months (i and j), 5 months (c and d), 6 months (g and h) and 8 months
(k and l) of age. Boxes in a and b are magnified in e and f, respectively. Bars: 200 µm (a, b, c, d, g, h, i, j, k and l) and 100 µm (e
and f).
doi: 10.1371/journal.pone.0074093.g003
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Figure 4.  MicroCT examination of lumbar vertebrae in each group.  a-j representative, transverse MicroCT images of the fifth
lumbar vertebra in wild-type and CA-β-catenin mice at 1 month (a and b), 3 months (c and d), 5 months (e and f), 6 months (g and
h) and 8 months (i and j) of age. k MicroCT analysis of BVF (BV/TV, %) of the fifth lumbar vertebra in CA-β-catenin mice and wild-
type mice. BV trabecular bone volume (mm3); TV total volume selected for analysis (mm3). l Trabecular number (Tb.N) of the fifth
lumbar vertebra in CA-β-catenin and wild-type mice. m Mean trabecular thickness (Tb.Th) of the fifth lumbar vertebra in CA-β-
catenin and wild-type mice. n Trabecular separation (Tb. Sp) of the fifth lumbar vertebra in CA-β-catenin and wild-type mice. Bars
represent the mean ± SEM (n=6 for each group). *p<0.05.
doi: 10.1371/journal.pone.0074093.g004
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Figure 5.  TRAP staining of lumbar vertebra in each group.  a-j TRAP staining of coronal sections of the fourth lumbar vertebra
in wild-type and CA-β-catenin mice at 1 month (a and b), 3 months (c and d), 6 months (e and f), and 8 months (g and h) of age.
Bars: 200 µm. i: The number of TRAP-positive cells in each group. j: The ratio of RANKL:OPG expression levels in each group.
Bars represent the mean ± SEM (n=6 for each group). *p<0.05.
doi: 10.1371/journal.pone.0074093.g005
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Figure 6.  Examination of markers for bone formation and maturation by immunohistochemistry (IHC).  a-d IHC against
TNAP in wild-type and CA-β-catenin mice at 1 month (a, b) and 6 months (c, d) of age. e: Number of TNAP-positive cells in each
group. f-i IHC against RunX2 in wild-type and CA-β-catenin mice at 1 month (f, g) and 6 months (h, i) of age. j: Number of RunX2-
positive cells in each group. k-n IHC against BSP in WT and CA-β-catenin mice at 1 month (k, l) and 6 months (m, n) of age. o
Number of BSP-positive cells in each group. Bars: 200 µm. Bars represent the mean ± SEM (n=6 for each group). *p<0.05.
doi: 10.1371/journal.pone.0074093.g006
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Figure 7.  Examination of markers for bone formation and bone resorption by Real-time PCR and EILISA.  a The mRNA
expression level of tissue non-specific alkaline phosphatase (TNAP) in each group. b The mRNA expression level of Runx2 in each
group. c The mRNA expression level of bone sialoprotein (BSP) in each group. d The mRNA expression level of tartrate resistant
acid phosphatase (TRAP) in each group. e The serum concentration of intact N-terminal propeptide of type I procollagen (P1NP) in
each group. f The serum concentration of osteocalcin in each group. g The serum concentration of C-terminal telopeptides of type I
collagen (CTX-I) in each group. h The serum concentration of tartrate resistant acid phosphatase 5b (TRAP5b) in each group. Bars
represent the mean ± SEM (n=6 for each group). *p<0.05.
doi: 10.1371/journal.pone.0074093.g007
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Supporting Information
Figure S1.  Site-specificity of Col1-CreERTM. a Col 1 Cre
expression was not found in growth plate in wild-type mice
crossed with ROSA26 mice. b Col 1 Cre expression was not
found in growth plate in Col1-CreERTM mice crossed with
ROSA26 mice. c Col 1 Cre expression was not found in
osteoblasts in wild-type mice crossed with ROSA26 mice. d Col
1 Cre expression was found in osteoblasts in Col1-CreERTM
mice crossed with ROSA26 mice. Bars: 200 µm.
(TIF)
Figure S2.  H&E staining of coronal sections of the tibia in
wild-type and CA-β-catenin mice. Boxes in a, c, e, g, I, k, m,
o, q and s are magnified in b, d, f, h, j, l, n, p, r and t,
respectively. Bars: 200 µm (a, c, e, g, I, k, m, o, q and s) and
100 µm (b, d, f, h, j, l, n, p, r and t).
(TIF)
Figure S3.  MicroCT examination of trabecular bone of
proximal tibia in each group. a-j representative, transverse
MicroCT images of the trabecular bone in CA-β-catenin and
wild-type mice at 1 month (a and b), 3 months (c and d), 5
months (e and f), 6 months (g and h) and 8 months (i and j) of
age. k MicroCT analysis of BVF (BV/TV, %) of the proximal
tibia in CA-β-catenin mice and wild-type mice. BV trabecular
bone volume (mm3); TV total volume selected for analysis
(mm3). l Trabecular number (Tb.N) of the proximal tibia in CA-
β-catenin and wild-type mice. m Mean trabecular thickness
(Tb.Th) of the proximal tibia in CA-β-catenin and wild-type
mice. n Trabecular separation (Tb. Sp) of the proximal tibia in
CA-β-catenin and wild-type mice. Bars represent the mean ±
SEM (n=6 for each group). * p<0.05.
(TIF)
Figure S4.  Safranin O staining of tibia in each group. a-h
Safranin O staining of coronal sections of tibia in wild-type and
CA-β-catenin mice at 1 month (a and b) 3 months (c,d g and h)
5 months (e and f), 6 months (i and j) and 8 months (k and l) of
age. Boxes in c and d are magnified in g and h, respectively.
Bars: 200 µm (a, b, c, d, e, f, i, j, k and l) and 100 µm (g and h).
(TIF)
Figure S5.  MicroCT examination of cortical bone of tibia in
each group. a-j representative, transverse MicroCT images of
the cortical bone in CA-β-catenin and wild-type mice at 1 month
(a and b), 3 months (c and d), 5 months (e and f), 6 months (g
and h) and 8 months (i and j) of age. k Total cross-sectional
area (Tt.Ar) in CA-β-catenin and wild-type mice. l Cortical bone
area (Ct.Ar) in CA-β-catenin and wild-type mice. m Cortical
area fraction (Ct.Ar/Tt.Ar) in CA-β-catenin and wild-type mice. n
Average cortical thickness (Ct.Th) in CA-β-catenin and wild-
type mice. Bars represent the mean ± SEM (n=6 for each
group). *p<0.05.
(TIF)
Figure S6.  TRAP staining of tibia in each group. a-h TRAP
staining of coronal sections of tibia in wild-type and CA-β-
catenin mice at 1 month (a and b), 3 months (c and d), 6
months (e and f), and 8 months (g and h) of age.
(TIF)
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